Status:
RECRUITING
A Study to Explore the Role of Gut Flora in COVID-19 Infection
Lead Sponsor:
ProgenaBiome
Conditions:
Gut Microbiome
Gastrointestinal Microbiome
Eligibility:
All Genders
18+ years
Brief Summary
This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.
Detailed Description
In this study the stool of patients who are being treated for COVID-19 will be tested during treatment and then again following treatment to determine if the virus is shed in the stool during infectio...
Eligibility Criteria
Inclusion Criteria:
- Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
- Male or female of 18 years of age or older
- Diagnosis of COVID-19 infection by RT- PCR within 1 week of Screening
Exclusion Criteria:
- Refusal to sign informed consent form
- History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
- Postoperative stoma, ostomy, or ileoanal pouch
- Treatment with total parenteral nutrition
Key Trial Info
Start Date :
April 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2027
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04359836
Start Date
April 16 2020
End Date
July 31 2027
Last Update
June 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ProgenaBiome
Ventura, California, United States, 93003